Ultralife (NASDAQ:ULBI) Raised to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Ultralife (NASDAQ:ULBIFree Report) from a buy rating to a strong-buy rating in a research report released on Wednesday morning.

Separately, Benchmark increased their target price on shares of Ultralife from $12.00 to $13.00 and gave the stock a buy rating in a report on Tuesday, March 5th.

Check Out Our Latest Stock Analysis on ULBI

Ultralife Price Performance

ULBI opened at $8.73 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 3.80 and a quick ratio of 2.02. Ultralife has a 1 year low of $3.92 and a 1 year high of $11.85. The stock’s 50 day simple moving average is $9.11 and its 200 day simple moving average is $8.18. The firm has a market cap of $143.61 million, a price-to-earnings ratio of 19.84 and a beta of 1.26.

Ultralife (NASDAQ:ULBIGet Free Report) last issued its earnings results on Thursday, February 15th. The technology company reported $0.18 earnings per share (EPS) for the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%. The firm had revenue of $44.55 million for the quarter.

Institutional Trading of Ultralife

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ULBI. EAM Investors LLC purchased a new position in Ultralife during the 3rd quarter valued at $1,776,000. Acadian Asset Management LLC purchased a new position in shares of Ultralife during the third quarter valued at about $1,039,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in Ultralife in the third quarter worth about $641,000. ClariVest Asset Management LLC purchased a new stake in Ultralife in the third quarter worth about $616,000. Finally, Navellier & Associates Inc. bought a new stake in Ultralife during the 4th quarter valued at approximately $310,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Ultralife Company Profile

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.